Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers…
03 June 2025 - The Olympic Refuge Foundation (ORF) Board met at Olympic House in Lausanne this week, to review the success of…
Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of the times and the advancement of technology, people's…
MUMBAI, India, June 3, 2025 /PRNewswire/ -- Sameer Kanodia, Managing Director and CEO, Lumina Datamatics, and Vice Chairman and CEO,…
June 03, 2025 01:00 ET | Source: argenx SE June 3, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the…
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…